Tag:

Fresenius SE

Latest Headlines

Latest Headlines

Analysts ponder takeover of ailing Hospira

Bloomberg speculates generics-maker Hospira ($HSP), currently limping with GMP remediation efforts across multiple manufacturing sites, is becoming attractive as a takeover target to other generics